It’s been 10 years since HealthEdge got its start and the healthcare software company is still standing. But that doesn’t mean it’s been standing still.
HealthEdge raises $30m for health insurance software
Allezoe Medical hopes to cradle organs to transplant
Allezoe Medical Holdings (OTC:ALZM) said its Organ Transport Systems subsidiary is preparing for clinical trials of the LifeCradle for preserving donated hearts before transplant.
The company, based in the Philippines, bought OTS in January. The move puts it on a collision course with TransMedics Inc., an Andover, Mass.-based which also has been developing an organ transport system.
Ronda Stryker sets up new stock-selling plan
Ronda Stryker is pruning one of the family trusts again, letting go of approximately 12 percent of its contents and setting up a payday somewhere close to $120 million — by far, her most profitable year yet selling Stryker Corp. (NYSE:SYK) stock.
Covidien wraps Solitaire FR clinicals early in bid for quick FDA review
Covidien plc (NYSE:COV) will take its Solitaire FR revascularization device directly to regulators rather than wait for additional clinical data, after an independent panel’s review of the data collected so far.
iCad sued for device acquired in Xoft Inc. acquisition
Xoft Inc. could turn out to be a lot more expensive for iCad (NSDQ:ICAD) than the $1 million in cash and the 8.47 million shares of stock it paid for the oncology device manufacturer late last year.
Fresenius snaps up dialysis monitor assets
Fresenius Medical Care AG (NYSE:FMS) shares are rebounding from earlier losses and were back to within 50 cents of even for today’s session at $68.14 each, after the German medical device manufacturer announced plans to acquire the Crit-Line system from privately held Hema Metrics. Terms of the deal were not immediately available.
Boston Scientific co-founder John Abele to leave board
Boston Scientific Corp. (NYSE:BSX) co-founder John Abele will not stand for re-election to the company’s board when his current term expires in May. Two other long-time board members — Marye Anne Fox and Ray Groves — also plan to step down.
Wall Street likes Cooper’s vision for the future
Buoyed by strong growth in the vision-care unit during its latest reporting period, The Cooper Companies Inc. (NYSE:COO) last night raised its earnings and revenue forecast for the rest of the year, sending the company’s stock on a tear when trading began this morning.
NeuroMetrix, Comerica Bank renew credit facility
Executives at NeuroMetrix Inc. (NSDQ:NURO) don’t appear to be in any rush to take on any new debt, but they could borrow up to $7.5 million after signing a one-year extension of a revolving credit facility with Comerica Bank.
Biolase gets a long look from investors after patent win
Biolase Technology Inc. (NSDQ:BLTI) stock is getting a big boost today, with shares climbing more than 16 percent to reach their best levels since June 2008 after the company received a U.S. patent for tools that make it easier to see structures inside the eye.
Fourth-quarter profits not enough for some Psychemedics investors
Psychemedics Corp. (NYSE:PMD) shares are down about 2 percent, paring earlier losses after the drug-testing firm turning in smaller fourth-quarter profits despite a 19.7 percent jump in Q4 revenues.
